Stepan Company
$ 50.21
-3.03%
15 Apr - close price
- Market Cap 1,174,908,000 USD
- Current Price $ 50.21
- High / Low $ 51.49 / 50.02
- Stock P/E 25.63
- Book Value 54.98
- EPS 2.02
- Next Earning Report 2026-04-28
- Dividend Per Share $1.55
- Dividend Yield 2.96 %
- Next Dividend Date -
- ROA 0.02 %
- ROE 0.04 %
- 52 Week High 67.47
- 52 Week Low 41.13
About
Stepan Company produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company is headquartered in Northfield, Illinois.
Analyst Target Price
$75.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-23 | 2025-10-29 | 2025-07-29 | 2025-04-28 | 2025-02-18 | 2024-10-30 | 2024-07-31 | 2024-04-30 | 2024-02-20 | 2023-10-18 | 2023-07-26 | 2023-04-25 |
| Reported EPS | -0.02 | 0.48 | 0.52 | 0.84 | 0.12 | 1.03 | 0.41 | 0.64 | 0.33 | 0.64 | 0.53 | 0.71 |
| Estimated EPS | 0.3968 | 0.62 | 0.8967 | 0.955 | 0.62 | 0.65 | 0.67 | 0.35 | 0.37 | 0.76 | 1.17 | 0.94 |
| Surprise | -0.4168 | -0.14 | -0.3767 | -0.115 | -0.5 | 0.38 | -0.26 | 0.29 | -0.04 | -0.12 | -0.64 | -0.23 |
| Surprise Percentage | -105.0403% | -22.5806% | -42.0096% | -12.0419% | -80.6452% | 58.4615% | -38.806% | 82.8571% | -10.8108% | -15.7895% | -54.7009% | -24.4681% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-28 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.32 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Jan 1970 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-13 | 2025-12-15 | None | 2025-06-13 | 2025-03-14 | 2024-12-13 | 2024-09-13 | 2024-06-14 | 2024-03-15 | 2023-12-15 |
| Amount | $0.395 | $0.395 | $0.385 | $0.385 | $0.385 | $0.385 | $0.375 | $0.375 | $0.375 | $0.375 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SCL
2026-04-15 20:27:04
Stepan Co's VP, Robin Joseph Weitkamp, received new equity awards as part of his compensation, including 2,859 restricted stock units, 4,030 stock appreciation rights with an exercise price of $52.46, and 1,429 performance shares. These grants, made on April 13, 2026, are contingent rights rather than open-market purchases and are designed to vest over time based on continued service and company performance goals through December 31, 2028. This SEC Form 4 filing details the specifics of these compensation awards, which align executive incentives with the company's long-term success.
2026-04-13 09:10:24
This report provides a comprehensive stock analysis of Stepan Company (NYSE:SCL), highlighting its current market valuation, future growth prospects, and financial health. The company is trading significantly below its estimated fair value, with anticipated earnings growth of 25.51% per year. Key takeaways emphasize potential revenue and earnings increases from specialty alkoxylation, a new Texas site, and a focus on acquiring new customers.
2026-04-12 20:10:29
This article displays the total debt per share for Stepan Co (LS:859510) and is hosted on TradingView. It provides financial data and indicates that the market is currently closed with no trades. The information is sourced from ICE Data Services, FactSet, American Bankers Association, and Quartr.
2026-04-11 12:40:16
Stepan Company (NYSE:SCL) has seen a decent share price growth of 17% recently, but it still falls short of its yearly peak. The stock's current valuation, with a P/E ratio of 25.31x, is slightly below its industry peers, suggesting it's reasonably priced. Analysts expect Stepan's earnings to increase by 66% in the coming years, indicating a positive outlook for the company's future growth and share value.
2026-04-10 15:10:03
Afonso Adriano Jose Galimberti, VP and GM Surfactants NA for STEPAN CO (NYSE: SCL), filed an initial ownership report detailing his equity holdings. The report outlines his ownership of stock options, stock appreciation rights (SARs), restricted stock units (RSUs), performance shares, and direct and indirect common stock, including shares held in an ESOP II trust. The filing provides a comprehensive overview of his equity incentives and current share ownership in the company.
2026-04-09 20:09:24
Stepan Company's VP and GM Surfactants-INT, Robin Joseph Weitkamp, has filed an initial ownership report detailing various equity-based awards. The filing includes restricted stock units (RSUs), stock appreciation rights (SARs), and performance shares, all representing contingent rights to Stepan common stock subject to vesting conditions and performance goals. Weitkamp also holds an indirect interest of 96.9 common shares through an ESOP II Trust.
